With our world's leading R&D platforms of multispecific antibodies and ADC drugs.

National Critical Innovative Drugs Special Projects: 9 Projects Received the Prestigious “13th Five-year Plan” Special Grant;

Designated Key Technology and Industrialization Special Project "2025 Industrial Transformation and Upgrading" Program in Pediatric Drugs sponsored by the Ministry of Industry and Information Technology.